How Courts Reviewed FDA Action Before Chevron and May Again After Loper Bright

Filing Litigation to Challenge FDA Delays in NDA or BLA Review

STAT+: FDA finalists under review

Three top contenders to run the FDA are under review by the White House

How Replimune’s drug got a third chance after the White House intervened

Replimune representatives met with White House officials in early May and by the end of month, the Food and Drug Administration was planning

This Week in 340B: June 30 – July 6, 2026

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we co

Unpacking the Consequences of the Decision in Monsanto Company v. Durnell

For more than a decade, litigation over glyphosate-based herbicides has sat at the intersection of federal pesticide regulation, state tort

STAT+: White House reviewing top contenders to lead FDA

The White House is reviewing finalists for FDA commissioner, suggesting the highly anticipated decision may come soon.